2017
DOI: 10.1016/j.bbmt.2017.05.001
|Get access via publisher |Cite
|
Sign up to set email alerts

Safety and Efficacy of Infliximab Therapy in the Setting of Steroid-Refractory Acute Graft-versus-Host Disease (V体育官网)

VSports在线直播 -

Abstract: Acute graft-versus-host disease (aGVHD) is the leading cause of morbidity and mortality after allogenic hematopoietic cell transplantation (HCT). Corticosteroids are the first-line treatment; however, less than one-half of patients achieve durable remission. Studies suggest that TNF-α, a cytokine released from the bone marrow during conditioning, is involved in the pathogenesis of aGVHD. We retrospectively evaluated the outcome of anti-TNF-α therapy with infliximab in 35 patients with steroid refractory (SR) a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
25
0

Year Published

2018
2018
2025
2025

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations

Cited by 39 publications (VSports手机版)

(26 citation statements)
references

References 42 publications (VSports app下载)

1
25
0
Order By: Relevance